← Leaderboards
Aaron M Newman
Stanford University
$4,320,927
Attributed
$5,009,485
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,009,485 · 4
By mechanism
R01$3,920,389 · 2
R00$747,000 · 1
K99$342,096 · 1
Top collaborators
- Aadel Chaudhuri2 shared
Most similar at Stanford University
Same institution · by research overlap
- Alexander D Boiko$3,037,060
- Julia Salzman$5,038,856
- Peter Poon-Hang Lee$6,837,790
- Joseph C Wu$80,370,369
- James Lewis Zehnder$1,190,101
Others in their field
Top investigators on “Validation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,091,456
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$239,311,963
Research focus
ValidationFoundationsMalignant NeoplasmsMortalityBioinformaticsMolecularTumorPublishingSingle-Cell Rna SequencingCohortLinkImmunotherapyInnovationCellsGenesCancer DetectionResponseSamplingBiopsyPlasmaBiological MarkersBenchmarkingBaseCessation Of Life
Grant awards (12)
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA$665,413
R01 · FY2025 · CA
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer$515,747
R01 · FY2025 · CA · contact PI
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA$711,704
R01 · FY2024 · CA
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer$489,960
R01 · FY2024 · CA · contact PI
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer$505,432
R01 · FY2023 · CA · contact PI
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer$515,747
R01 · FY2022 · CA · contact PI
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer$516,386
R01 · FY2021 · CA · contact PI
Ultrasensitive Quantitation of Circulating Tumor DNA$249,000
R00 · FY2019 · CA · contact PI
Ultrasensitive Quantitation of Circulating Tumor DNA$249,000
R00 · FY2018 · CA · contact PI
Ultrasensitive Quantitation of Circulating Tumor DNA$249,000
R00 · FY2017 · CA · contact PI
Ultrasensitive Quantitation of Circulating Tumor DNA$171,048
K99 · FY2016 · CA · contact PI
Ultrasensitive Quantitation of Circulating Tumor DNA$171,048
K99 · FY2015 · CA · contact PI